NCOA3 and lung carcinoma: ERK3 stimulates lung cancer cell invasiveness both in vitro and in vivo by phosphorylating steroid receptor coactivator 3 (SRC3) oncoprotein and upregulating SRC3-mediated matrix metalloproteinase (MMP) gene expression7.